Scpharmaceuticals INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$2.8Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
16,091clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Hunter Champion | Columbus, GA | Cardiovascular Disease | $174,752.56 |
| William Abraham | Columbus, OH | Advanced Heart Failure and Transplant Cardiology | $133,127.44 |
| Daniel Bensimhon | Greensboro, NC | Advanced Heart Failure and Transplant Cardiology | $105,372.76 |
| Georges Chahoud | Saint Louis, MO | Cardiovascular Disease | $71,747.84 |
| Vamsi Krishna | Kyle, TX | Interventional Cardiology | $67,248.38 |
| Gautam Shah | Fairview Park, OH | Cardiovascular Disease | $64,263.05 |
| Benjamin Kalsmith | Pgh, PA | Cardiovascular Disease | $62,915.96 |
| Erika Feller | Baltimore, MD | Cardiovascular Disease | $61,016.99 |
| Rigved Tadwalkar | Santa Monica, CA | Cardiovascular Disease | $58,750.13 |
| Amin Yehya | Norfolk, VA | Advanced Heart Failure and Transplant Cardiology | $53,786.20 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.